Newsbenzinga
Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device
· Published
Article summary
CMS proposes easing TAVR coverage rules and expanding access, a move analysts say could strengthen Edwards Lifesciences' market position.
An excerpt from the original article.
Comments —
Loading comments…